A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy

BACKGROUND: Recently, relugolix, an oral gonadotropin-releasing hormone receptor antagonist, has been considered an effective therapy for leiomyoma based on a phase 3 study in Japanese women. Leiomyoma combined with severe adenomyosis occasionally occurs in perimenopausal women; however, little info...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasamori, Yukifumi, Takehara, Kohei, Terashima, Tsuyoshi, Onodera, Takako, Yatsuki, Keita, Nakagawa, Ippei, Takahashi, Yuko, Nishida, Haruka, Ichinose, Takayuki, Hiraike, Haruko, Nagasaka, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375059/
https://www.ncbi.nlm.nih.gov/pubmed/34412607
http://dx.doi.org/10.1186/s12905-021-01442-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375059/
https://www.ncbi.nlm.nih.gov/pubmed/34412607
http://dx.doi.org/10.1186/s12905-021-01442-x

Ejemplares similares